In depth knowledge of the life sciences sector is key to our effectiveness as legal advisers to clients in this sector.
This combined with our genuine understanding of the complex scientific issues and the technical ability of our dedicated international team of lawyers ensures we are uniquely capable of understanding our clients' business objectives and of developing innovative solutions to the legal and commercial issues arising in this fast moving sector.
Through working at the forefront of developments within this sector, we have built considerable experience in acting for a range of businesses from the largest global pharmaceutical companies to emerging bioscience ventures advising on a broad range of matters from the initial start-up through IPO and beyond.
The international corporate finance team has the experience and know-how to handle the most complex international and domestic corporate finance and private equity transactions. The team's private equity experience includes buyouts, venture or development capital investments and debt finance. We have acted for many pharmaceutical and biosciences companies in start-up and intermediate fund raisings, including their listing on the London Stock Exchange, the Alternative Investment Market in London and the Nasdaq in the US. Our leading reputation in the new technology field, combined with our private equity expertise, ensures we regularly advise institutions, management and technology based businesses on private equity work.
Drawing on other core areas of strength within the firm, we regularly advise pharmaceutical and biosciences companies on a wide range of matters including their internet strategies, data protection, IT and software issues relating to bioinformatics, patent litigation often co-ordinating actions on a pan-European basis.
Our full service capability ensures we provide a comprehensive range of legal services with a clear focus on issues that are relevant to the industry sector.